Pharma Companies May Benefit from Proposed Patent Law Changes in China; Public Comment Invited

Published date09 January 2019
Law FirmHogan Lovells
AuthorPhilip Katz, Lu Zhou, Zhen Feng and Xin Tao
Subject MatterAdministrative

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT